Zhejiang Dayang Biotech Group Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 12.50% vs 27.75% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 5.46% vs 73.37% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "278.10",
          "val2": "247.20",
          "chgp": "12.50%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "28.00",
          "val2": "40.60",
          "chgp": "-31.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.80",
          "val2": "1.00",
          "chgp": "-20.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-0.40",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "30.90",
          "val2": "29.30",
          "chgp": "5.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "100.70%",
          "val2": "98.20%",
          "chgp": "0.25%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is -1.05% vs -13.13% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 27.40% vs -38.04% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "906.70",
          "val2": "916.30",
          "chgp": "-1.05%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "132.70",
          "val2": "112.40",
          "chgp": "18.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.30",
          "val2": "6.70",
          "chgp": "8.96%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-6.50",
          "val2": "-18.50",
          "chgp": "64.86%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "63.70",
          "val2": "50.00",
          "chgp": "27.40%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "70.60%",
          "val2": "47.70%",
          "chgp": "2.29%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

278.10

247.20

12.50%

Operating Profit (PBDIT) excl Other Income

28.00

40.60

-31.03%

Interest

0.80

1.00

-20.00%

Exceptional Items

0.00

-0.40

100.00%

Consolidate Net Profit

30.90

29.30

5.46%

Operating Profit Margin (Excl OI)

100.70%

98.20%

0.25%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 12.50% vs 27.75% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 5.46% vs 73.37% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'24

Dec'24

Dec'23

Change(%)

Net Sales

906.70

916.30

-1.05%

Operating Profit (PBDIT) excl Other Income

132.70

112.40

18.06%

Interest

7.30

6.70

8.96%

Exceptional Items

-6.50

-18.50

64.86%

Consolidate Net Profit

63.70

50.00

27.40%

Operating Profit Margin (Excl OI)

70.60%

47.70%

2.29%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2024 is -1.05% vs -13.13% in Dec 2023

Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 27.40% vs -38.04% in Dec 2023

All Annual Results